Shiraz E-Medical Journal

Published by: Kowsar

Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

SM Alavian 1 , * , A Kabir 2 , B Hajarizadeh 3 , M Nayebpour 4 , T Dorodi 3 and FE Baralle 5
Authors Information
1 Associate professor; Department Medicine, Section of Gastroenterology, Baghiatollah University of Medical Sciences; Dean of Tehran Hepatitis Center, Tehran, Iran
2 Methodology and statistics consultant; Tehran Hepatitis Center, Tehran, Iran
3 Research Fellow, Tehran Hepatitis Center, Tehran, Iran
4 Assistant professor of pharmacology, Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, Iran
5 Professor and Director of International Center for Genetic Engineering and Biotechnology, Trieste, Italy
Article information
  • Shiraz E-Medical Journal: 7 (1); 1-8
  • Published Online: January 1, 2006
  • Article Type: Research Article

To Cite: Alavian S, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, et al. Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study, Shiraz E-Med J. Online ahead of Print ; 7(1):20390.

Abstract
© 2006, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments